These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 14736523

  • 1. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma.
    Ikeguchi M, Oi K, Hirooka Y, Kaibara N.
    Eur J Surg Oncol; 2004 Feb; 30(1):53-7. PubMed ID: 14736523
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
    Chew V, Tow C, Teo M, Wong HL, Chan J, Gehring A, Loh M, Bolze A, Quek R, Lee VK, Lee KH, Abastado JP, Toh HC, Nardin A.
    J Hepatol; 2010 Mar; 52(3):370-9. PubMed ID: 19720422
    [Abstract] [Full Text] [Related]

  • 3. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
    Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, Lim KH, Weber A, Chow P, Chung A, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Chen Q, Abastado JP, Chew V.
    Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
    [Abstract] [Full Text] [Related]

  • 4. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
    Zhang M, Pang HJ, Zhao W, Li YF, Yan LX, Dong ZY, He XF.
    BMC Cancer; 2018 May 02; 18(1):511. PubMed ID: 29720116
    [Abstract] [Full Text] [Related]

  • 5. Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma.
    Weng Q, Chen M, Li M, Zheng YF, Shao G, Fan W, Xu XM, Ji J.
    J Med Genet; 2019 Jan 02; 56(1):32-38. PubMed ID: 30120213
    [Abstract] [Full Text] [Related]

  • 6. PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma.
    Ma J, Zheng B, Goswami S, Meng L, Zhang D, Cao C, Li T, Zhu F, Ma L, Zhang Z, Zhang S, Duan M, Chen Q, Gao Q, Zhang X.
    J Immunother Cancer; 2019 Nov 29; 7(1):331. PubMed ID: 31783783
    [Abstract] [Full Text] [Related]

  • 7. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.
    Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N.
    Gastric Cancer; 2002 Nov 29; 5(4):220-7. PubMed ID: 12491080
    [Abstract] [Full Text] [Related]

  • 8. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr 29; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 9. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
    Pan QZ, Pan K, Zhao JJ, Chen JG, Li JJ, Lv L, Wang DD, Zheng HX, Jiang SS, Zhang XF, Xia JC.
    Cancer Immunol Immunother; 2013 Nov 29; 62(11):1675-85. PubMed ID: 24061617
    [Abstract] [Full Text] [Related]

  • 10. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
    Ikeguchi M, Hirooka Y, Kaibara N.
    Anticancer Res; 2003 Nov 29; 23(6D):4967-71. PubMed ID: 14981953
    [Abstract] [Full Text] [Related]

  • 11. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma.
    Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, Taguchi K, Kotoh K, Shimada M, Sugimachi K, Tsuneyoshi M, Nawata H, Watanabe T.
    Cancer Lett; 2001 Jul 26; 168(2):197-202. PubMed ID: 11403925
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.
    Xu X, Tan Y, Qian Y, Xue W, Wang Y, Du J, Jin L, Ding W.
    Medicine (Baltimore); 2019 Jan 26; 98(2):e13923. PubMed ID: 30633166
    [Abstract] [Full Text] [Related]

  • 13. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
    Kang HJ, Oh JH, Chun SM, Kim D, Ryu YM, Hwang HS, Kim SY, An J, Cho EJ, Lee H, Shim JH, Sung CO, Yu E.
    J Hepatol; 2019 Jul 26; 71(1):91-103. PubMed ID: 30930222
    [Abstract] [Full Text] [Related]

  • 14. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M, Sturm N, Decaens T, Bioulac-Sage P, Bancel B, Merle P, Tran Van Nhieu J, Slama R, Letoublon C, Zarski JP, Jouvin-Marche E, Marche PN, Leroy V.
    Liver Int; 2016 Mar 26; 36(3):434-44. PubMed ID: 26215124
    [Abstract] [Full Text] [Related]

  • 15. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y, Takahashi K, Furuta K, Tagaya T, Ishikawa T, Wada K, Omoto Y, Koji T, Kakumu S.
    J Gastroenterol; 2001 Oct 26; 36(10):681-8. PubMed ID: 11686478
    [Abstract] [Full Text] [Related]

  • 16. Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma.
    Guo CL, Yang HC, Yang XH, Cheng W, Dong TX, Zhu WJ, Xu Z, Zhao L.
    Asian Pac J Cancer Prev; 2012 Oct 26; 13(11):5909-13. PubMed ID: 23317279
    [Abstract] [Full Text] [Related]

  • 17. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H.
    J Surg Oncol; 2005 May 01; 90(2):89-94. PubMed ID: 15844180
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
    Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M.
    Hepatology; 1998 Feb 01; 27(2):407-14. PubMed ID: 9462638
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.
    Chen CH, Lee HS, Huang GT, Yang PM, Yu WY, Cheng KC, Lee PH, Jeng YM, Chen DS, Sheu JC.
    Hepatogastroenterology; 2007 Feb 01; 54(77):1529-33. PubMed ID: 17708291
    [Abstract] [Full Text] [Related]

  • 20. Clinico-pathological significance of RCAS1 expression in gliomas: a potential mechanism of tumor immune escape.
    Nakabayashi H, Nakashima M, Hara M, Toyonaga S, Yamada SM, Park KC, Shimizu K.
    Cancer Lett; 2007 Feb 08; 246(1-2):182-9. PubMed ID: 16595162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.